Corient Private Wealth
RGEN icon

Corient Private Wealth’s Repligen RGEN Stock Holding History

Corient Private Wealth’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$252K Sell
2,173
-2,772
-56% -$387K ﹤0.01% 2420
2025
Q4 		$814K Buy
4,945
+645
+15% +$101K ﹤0.01% 2004
2025
Q3 		$575K Buy
4,300
+628
+17% +$76.3K ﹤0.01% 1718
2025
Q2 		$457K Buy
3,672
+52
+1% +$6.62K ﹤0.01% 1750
2025
Q1 		$461K Buy
3,620
+339
+10% +$52.2K ﹤0.01% 1638
2024
Q4 		$472K Sell
3,281
-405
-11% -$58.1K ﹤0.01% 1654
2024
Q3 		$549K Sell
3,686
-2,220
-38% -$318K ﹤0.01% 1687
2024
Q2 		$745K Sell
5,906
-1,221
-17% -$191K ﹤0.01% 1455
2024
Q1 		$1.31M Buy
7,127
+116
+2% +$22.1K ﹤0.01% 1219
2023
Q4 		$1.26M Buy
7,011
+1,532
+28% +$238K ﹤0.01% 1201
2023
Q3 		$872K Buy
5,479
+2,918
+114% +$477K ﹤0.01% 1245
2023
Q2 		$362K Sell
2,561
-1,613
-39% -$259K ﹤0.01% 1615
2023
Q1 		$705K Buy
4,174
+883
+27% +$158K ﹤0.01% 1229
2022
Q4 		$551K Buy
+3,291
New +$597K ﹤0.01% 1109

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Corient Private Wealth's RGEN Position: Q1 2026 in Review

Corient Private Wealth reduced its Repligen (RGEN) stake by 56% in Q1 2026, selling an estimated $387K and leaving 2,173 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

Corient Private Wealth first reported a position in RGEN in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.31M in Q1 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Corient Private Wealth held 2,173 shares of Repligen worth $252K as of Q1 2026.
  • Corient Private Wealth sold 2,772 Repligen shares in Q1 2026, an estimated $387K.
  • Repligen made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2420 holding.
  • Corient Private Wealth first reported a position in Repligen in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Repligen position peaked at $1.31M in Q1 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.